FDA approves Xolair as first and only medicine for children and adults with one or more food allergies – Genentech/Roche + Novartis
Roche announced that the FDA has approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one or more foods… read more.
